Publications by authors named "Erica Bonazzina"

Claim this Profile
T
Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.
Alessio Amatu, Giorgio Patelli, Maria Giulia Zampino, Francesca Bergamo, Stefania Mosconi, Erica Bonazzina

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies.
Caterina Vaghi, Federica Tosi, Gianluca Mauri, Erica Bonazzina, Alessio Amatu

Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characterisation of alterations in gastrointestinal cancers.
Gianluca Mauri, Giorgio Patelli, Laura Roazzi, Emanuele Valtorta, Alessio Amatu, Erica Bonazzina

J Clin Pathol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer.
Laura Roazzi, Giorgio Patelli, Katia Bruna Bencardino, Alessio Amatu, Erica Bonazzina

Clin Colorectal Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for Gene Promoter Hypermethylation Detection.
Marco Macagno, Valeria Pessei, Noemi Congiusta, Luca Lazzari, Sara Erika Bellomo, Erica Francesca Bonazzina

Diagnostics (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young-onset colorectal cancer: treatment-related nausea, vomiting and diarrhoea.
Gianluca Mauri, Martino Pedrani, Silvia Ghezzi, Katia Bencardino, Sara Mariano, Erica Bonazzina

BMJ Support Palliat Care· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer.
Giorgio Patelli, Gianluca Mauri, Federica Tosi, Alessio Amatu, Katia Bencardino, Erica Bonazzina

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Case report: mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Gianluca Mauri, Giorgio Patelli, Viviana Gori, Calogero Lauricella, Benedetta Mussolin, Erica Bonazzina

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Gianluca Mauri, Giorgio Patelli, Viviana Gori, Calogero Lauricella, Benedetta Mussolin, Erica Bonazzina

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study.
Alessio Amatu, Gianluca Mauri, Federica Tosi, Katia Bencardino, Erica Bonazzina

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.
Giorgio Patelli, Caterina Vaghi, Federica Tosi, Gianluca Mauri, Alessio Amatu, Erica Bonazzina

Target Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.
Giorgio Patelli, Caterina Vaghi, Federica Tosi, Gianluca Mauri, Alessio Amatu, Erica Bonazzina

Target Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolutionary Landscape of Treatment for Mutant Metastatic Colorectal Cancer.
Gianluca Mauri, Erica Bonazzina, Alessio Amatu, Federica Tosi, Katia Bencardino

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer.
Federica Tosi, Andrea Sartore-Bianchi, Sara Lonardi, Alessio Amatu, Francesco Leone, Erica Bonazzina

Clin Colorectal Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities.
Gianluca Mauri, Viviana Gori, Erica Bonazzina, Alessio Amatu, Federica Tosi

Cancer Treat Rev· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
Alessio Amatu, Marta Schirripa, Federica Tosi, Sara Lonardi, Katia Bencardino, Erica Bonazzina

Front Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies.
Gianluca Mauri, Elio Gregory Pizzutilo, Alessio Amatu, Katia Bencardino, Laura Palmeri, Erica Francesca Bonazzina

Cancer Treat Rev· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRKA expression and gene copy number across solid tumours.
Gianluca Mauri, Emanuele Valtorta, Giulio Cerea, Alessio Amatu, Michele Schirru, Erica Francesca Bonazzina

J Clin Pathol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.
Giulia Siravegna, Luca Lazzari, Giovanni Crisafulli, Andrea Sartore-Bianchi, Benedetta Mussolin, Erica Bonazzina

Cancer Cell· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.
Andrea Sartore-Bianchi, Alessio Amatu, Erica Bonazzina, Stefano Stabile, Laura Giannetta

Target Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study.
Katia Bencardino, Gianluca Mauri, Alessio Amatu, Federica Tosi, Erica Bonazzina

Clin Colorectal Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution and - coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer.
Andrea Sartore-Bianchi, Emanuele Valtorta, Alessio Amatu, Silvio Veronese, Calogero Lauricella, Erica Bonazzina

ESMO Open· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
Andrea Sartore-Bianchi, Elena Ardini, Roberta Bosotti, Alessio Amatu, Emanuele Valtorta, Erica Bonazzina

J Natl Cancer Inst· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.
Bruno Vincenzi, Chiara Cremolini, Andrea Sartore-Bianchi, Antonio Russo, Francesco Mannavola, Erica Bonazzina

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis